Skip to content

Psychometric Validation of the Antillanisée Version of the Mini Mental State Examination (MMSEa)

Psychometric Validation of the Antillanisée Version of the Mini Mental State Examination

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03324711
Acronym
MMENSEA
Enrollment
75
Registered
2017-10-30
Start date
2016-11-15
Completion date
2019-07-31
Last updated
2022-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Cognitive Disorder, Elderly Patients

Keywords

Cognitive disorders, Alzheimer's disease, Mini Mental State Examination, Geriatry

Brief summary

The main objective of the study is to analyze the psychometric properties of the antillanisée version of the Mini Mental State Examination (MMSEa). The methodology used will permit to explore the feasibility, acceptability, validity and reliability of the tool. The psychometric validation of a version adapted transculturally will increase the value of the results obtained with this test and will make it possible to refine the screening of existing cognitive disorders for elderly subjects with Alzheiner's disease or related disorders.

Detailed description

Patients will be recruited at the Geriatric Day Hospital. These patients came to a geriatric day hospital for examination without restriction on the reason for the hospitalization. They are referred by their general practitionner or referred by a specialist physician, live at home or in an institution and are representative of the geriatric population addressed by the MMSEa. * The main objective of the study is to analyze the psychometric properties of the antillanisée version of the Mini Mental State Examination (MMSEa). * The ancillary objective of this study will be to carry out the psychometric validation of the Short Physical Performance Battery (SPPB) in people aged 65 years or older. It is an instrument for measuring the physical performance of subjects whose transcultural adaptation and psychometric validation have already been performed in subjects aged 65 to 74 years. SPPB is used routinely in our routine practice in a day hospital, with no psychometric validation performed on this population. This ancillary objective will not modify the course of the MMSEa validation study since the SPPB is part of the evaluation tools.

Interventions

DIAGNOSTIC_TESTAntillanisée Mini Mental State Examination (MMSEa)

Antillanisée version of the Mini Mental State Examination (MMSEa), is a version adaptated to the French West Indies creole culture.

Sponsors

University Hospital Center of Martinique
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject of 65 years old and over * Subject admitted in a geriatric day hospital * Patients of creole culture * Subject having French and/or Creole as mother tongue * Subject able to undergo neuropsychological tests * Subject having given informed consent or, informed consent given by his or her primary caregiver * Subject affiliated to a social security scheme

Exclusion criteria

* Subject with a disability seriously compromising oral communication (understanding and expression) * Subject with behavioral disorder that does not allow for testing * Subject in general condition not allowing its participation in the tests * Subject involved in another study including an exclusion period still in progress at the time of inclusion

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the psychometric properties of the questionnaire MMSEa12 month (+/- 15 days)The following will be measured: * feasibility and acceptability; * validity of structure; * discriminant validity; * predictive validity; * validity of convergence; * reliability (internal consistency,reproducibility (test-retest)).

Secondary

MeasureTime frameDescription
Evaluation of the psychometric properties of questionnaire SPPB12 month (+/- 15 days)The following will be measured: * feasibility and acceptability; * validity of structure; * discriminant validity; * predictive validity; * reliability (internal consistency,reproducibility (test-retest)).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026